Gonsalves, Wilson I.
Buadi, Francis K.
Ailawadhi, Sikander
Bergsagel, P. Leif http://orcid.org/0000-0003-1523-7388
Chanan Khan, Asher A.
Dingli, David
Dispenzieri, Angela
Fonseca, Rafael
Hayman, Susan R.
Kapoor, Prashant
Kourelis, Taxiarchis V.
Lacy, Martha Q.
Larsen, Jeremy T.
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Reeder, Craig B.
Sher, Taimur
Stewart, A. Keith
Warsame, Rahma
Go, Ronald S.
Kyle, Robert A.
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Lin, Yi
Lust, John A.
Russell, Stephen J.
Zeldenrust, Stephen R.
Fonder, Amie L.
Hwa, Yi L.
Hobbs, Miriam A.
Mayo, Angela A.
Hogan, William J. http://orcid.org/0000-0002-5841-4105
Rajkumar, S. Vincent
Kumar, Shaji K.
Gertz, Morie A.
Roy, Vivek
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA218742, CA186781)
Article History
Received: 15 April 2018
Revised: 10 May 2018
Accepted: 11 May 2018
First Online: 9 July 2018
Compliance with ethical standards
:
: Dr. Dingli has received research funding from Millenium/Takeda. Dr. Ailawadhi has received grants and other support from Takeda Oncology. Dr. Bergsagel has received support from Millenium and Celgene. Dr. Dispenzieri has received grants from Celgene and Takeda. Dr. Gertz has received personal fees from Celgene. Dr. Kapoor has received research funding from Takeda and Celgene. Dr. Kumar has received consultancy fees from Millennium/Takeda and Celgene. Dr. Lacy has received grants from Celgene. The remaining authors declare that they have no conflict of interest.